Lacticaseibacillus casei AMBR2 modulates the epithelial barrier function and immune response in a donor-derived nasal microbiota manner

Live biotherapeutic products (LBP) are emerging as alternative treatment strategies for chronic rhinosinusitis. The selection of interesting candidate LBPs often involves model systems that do not include the polymicrobial background (i.e. the host microbiota) in which they will be introduced. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: De Rudder, Charlotte, Garcia-Tímermans, Cristina, De Boeck, Ilke, Lebeer, Sarah, Van de Wiele, Tom, Calatayud Arroyo, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547715/
https://www.ncbi.nlm.nih.gov/pubmed/33037304
http://dx.doi.org/10.1038/s41598-020-73857-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547715/
https://www.ncbi.nlm.nih.gov/pubmed/33037304
http://dx.doi.org/10.1038/s41598-020-73857-9

Ejemplares similares